UB Paderborn / Katalog / Suche / in CDI

Mutational profile and prognostic significance of TP53 in diffuse large B-cell lymphoma patients treated with R-CHOP: report from an International DLBCL Rituximab-CHOP Consortium Program Study

Blood, 2012-11, Vol.120 (19), p.3986-3996

2012

Link zum Volltext

Verfügbarkeit prüfen

Down-regulation of eIF4GII by miR-520c-3p represses diffuse large B cell lymphoma development

PLoS genetics, 2014-01, Vol.10 (1), p.e1004105-e1004105

2014

Link zum Volltext

Verfügbarkeit prüfen

Functional and molecular interactions between ERK and CHK2 in diffuse large B-cell lymphoma

Nature communications, 2011-07, Vol.2 (1), p.402-402, Article 402

2011

Link zum Volltext

Verfügbarkeit prüfen

Atypical presentation of Whipple disease with no diarrhea

Indian journal of pathology & microbiology, 2015-07, Vol.58 (3), p.398-399

2015

Link zum Volltext

Verfügbarkeit prüfen

Phospho-p70S6K/p85S6K and cdc2/cdk1 Are Novel Targets for Diffuse Large B-Cell Lymphoma Combination Therapy

Clinical cancer research, 2009-03, Vol.15 (5), p.1708-1720

2009

Link zum Volltext

Verfügbarkeit prüfen

Plasmablastic lymphoma of the oral cavity: a rapidly progressive lymphoma associated with HIV infection

The Lancet infectious diseases, 2008-04, Vol.8 (4), p.261-267

2008

Link zum Volltext

Verfügbarkeit prüfen

Patients with diffuse large B-cell lymphoma of germinal center origin with BCL2 translocations have poor outcome, irrespective of MYC status: a report from an International DLBCL rituximab-CHOP Consortium Program Study

Haematologica (Roma), 2013-02, Vol.98 (2), p.255-263

2013

Link zum Volltext

Verfügbarkeit prüfen

Angiolymphoid hyperplasia with eosinophilia developing in a patient with history of peripheral T-cell lymphoma: evidence for multicentric T-cell lymphoproliferative process

Diagnostic pathology, 2008-05, Vol.3 (1), p.22-22, Article 22

2008

Link zum Volltext

Verfügbarkeit prüfen

Antimetastatic activity isolated from Colocasia esculenta (taro)

Anti-cancer drugs, 2012-02, Vol.23 (2), p.200-211

2012

Link zum Volltext

Verfügbarkeit prüfen

Extracellular Signal-Regulated Kinase Positively Regulates the Oncogenic Activity of MCT-1 in Diffuse Large B-Cell Lymphoma

Cancer research (Chicago, Ill.), 2009-10, Vol.69 (19), p.7835-7843

2009

Link zum Volltext

Verfügbarkeit prüfen

Primary gastric T cell lymphoma mimicking marginal zone B cell lymphoma of mucosa-associated lymphoid tissue

Journal of hematopathology, 2008-07, Vol.1 (1), p.29-35

2008

Link zum Volltext

Verfügbarkeit prüfen

Extra-oral plasmablastic lymphoma: report of a case and review of literature

Human pathology, 2006-09, Vol.37 (9), p.1233-1236

2006

Link zum Volltext

Verfügbarkeit prüfen

Nodular lymphocyte-predominant hodgkin lymphoma or T-cell/histiocyte rich large B-cell lymphoma: the problem in "grey zone" lymphomas

International journal of clinical and experimental pathology, 2008-01, Vol.1 (3), p.300-305

Zhao, Frank X

2008

Link zum Volltext

Verfügbarkeit prüfen

Optimizing antibody panels for efficient and cost‐effective flow cytometric diagnosis of acute leukemia

Cytometry. Part B, Clinical cytometry, 2011-07, Vol.80B (4), p.221-229

2011

Link zum Volltext

Verfügbarkeit prüfen

Alcohol consumption and decreased risk of non-Hodgkin lymphoma: role of mTOR dysfunction

Blood, 2009-05, Vol.113 (22), p.5526-5535

2009

Link zum Volltext

Verfügbarkeit prüfen

Pathogenesis of early leukemia and lymphoma

Cancer biomarkers : section A of Disease markers, 2011-01, Vol.9 (1-6), p.341

2011

Link zum Volltext

Verfügbarkeit prüfen

Pediatric primary bone lymphoma-diffuse large B-cell lymphoma : Morphologic and immunohistochemical characteristics of 10 cases

American journal of clinical pathology, 2007, Vol.127 (1), p.47-54

2007

Link zum Volltext

Verfügbarkeit prüfen

Large B-cell lymphoma with an unusual infiltrating pattern: report of two cases

International journal of clinical and experimental pathology, 2010-10, Vol.3 (8), p.815-821

2010

Link zum Volltext

Verfügbarkeit prüfen

The RUNX2 Transcription Factor Negatively Regulates SIRT6 Expression to Alter Glucose Metabolism in Breast Cancer Cells

Journal of cellular biochemistry, 2015-10, Vol.116 (10), p.2210-2226

2015

Link zum Volltext

Verfügbarkeit prüfen

Persistent positron emission tomography positivity secondary to benign histiocytic proliferation after treatment of Hodgkin lymphoma

Leukemia & lymphoma, 2007-01, Vol.48 (3), p.616-618

2007

Link zum Volltext

Verfügbarkeit prüfen

Down-Regulation of eIF4GII by miR-520c-3p Represses Diffuse Large B Cell Lymphoma Development: e1004105

PLoS genetics, 2014-01, Vol.10 (1)

2014

Link zum Volltext

Verfügbarkeit prüfen

The t(14;18)(q32;q21) Characterizes a Subset of Patients with Diffuse Large-B Cell Lymphoma of Germinal Center Origin with Poor Outcome: Report From the International DLBCL Rituximab-CHOP Consortium Program Study

Blood, 2011-11, Vol.118 (21), p.949-949

2011

Link zum Volltext

Verfügbarkeit prüfen

Mutational Profile and Prognostic Significance of TP53 in Diffuse Large B-cell Lymphoma Patients Treated with Rituximab-CHOP: A Report From an International DLBCL Rituximab-CHOP Consortium Program Study

Clinical lymphoma, myeloma and leukemia, 2013-09, Vol.13, p.S382-S382

2013

Link zum Volltext

Verfügbarkeit prüfen

MYC/BCL2 Protein Co-Expression Defines a Unique Subset of Aggressive Lymphoma and Contributes to the Inferior Prognosis of Activated B-cell Subtype of Diffuse Large B-cell Lymphoma: A Report from the International DLBCL Rituximab-CHOP Consortium Program Study

Clinical lymphoma, myeloma and leukemia, 2013-09, Vol.13, p.S382-S383

2013

Link zum Volltext

Verfügbarkeit prüfen

Menü

Weitere Dienste

Einstellungen

Mutational profile and prognostic significance of TP53 in diffuse large B-cell lymphoma patients treated with R-CHOP: report from an International DLBCL Rituximab-CHOP Consortium Program Study

Down-regulation of eIF4GII by miR-520c-3p represses diffuse large B cell lymphoma development

Functional and molecular interactions between ERK and CHK2 in diffuse large B-cell lymphoma

Atypical presentation of Whipple disease with no diarrhea

Phospho-p70S6K/p85S6K and cdc2/cdk1 Are Novel Targets for Diffuse Large B-Cell Lymphoma Combination Therapy

Plasmablastic lymphoma of the oral cavity: a rapidly progressive lymphoma associated with HIV infection

Patients with diffuse large B-cell lymphoma of germinal center origin with BCL2 translocations have poor outcome, irrespective of MYC status: a report from an International DLBCL rituximab-CHOP Consortium Program Study

Angiolymphoid hyperplasia with eosinophilia developing in a patient with history of peripheral T-cell lymphoma: evidence for multicentric T-cell lymphoproliferative process

Antimetastatic activity isolated from Colocasia esculenta (taro)

Extracellular Signal-Regulated Kinase Positively Regulates the Oncogenic Activity of MCT-1 in Diffuse Large B-Cell Lymphoma

Primary gastric T cell lymphoma mimicking marginal zone B cell lymphoma of mucosa-associated lymphoid tissue

Extra-oral plasmablastic lymphoma: report of a case and review of literature

Nodular lymphocyte-predominant hodgkin lymphoma or T-cell/histiocyte rich large B-cell lymphoma: the problem in "grey zone" lymphomas

Optimizing antibody panels for efficient and cost‐effective flow cytometric diagnosis of acute leukemia

Alcohol consumption and decreased risk of non-Hodgkin lymphoma: role of mTOR dysfunction

Pathogenesis of early leukemia and lymphoma

Pediatric primary bone lymphoma-diffuse large B-cell lymphoma : Morphologic and immunohistochemical characteristics of 10 cases

Large B-cell lymphoma with an unusual infiltrating pattern: report of two cases

The RUNX2 Transcription Factor Negatively Regulates SIRT6 Expression to Alter Glucose Metabolism in Breast Cancer Cells

Persistent positron emission tomography positivity secondary to benign histiocytic proliferation after treatment of Hodgkin lymphoma

Down-Regulation of eIF4GII by miR-520c-3p Represses Diffuse Large B Cell Lymphoma Development: e1004105

Prognostic Significance and Phenotypic Manifestations of MYC/BCL2 Protein Expression in Diffuse Large B-Cell Lymphoma (DLBCL) with Extranodal Organ Involvement: A Report of the International DLBCL Rituximab-CHOP Consortium Program Study

The t(14;18)(q32;q21) Characterizes a Subset of Patients with Diffuse Large-B Cell Lymphoma of Germinal Center Origin with Poor Outcome: Report From the International DLBCL Rituximab-CHOP Consortium Program Study

Mutational Profile and Prognostic Significance of TP53 in Diffuse Large B-cell Lymphoma Patients Treated with Rituximab-CHOP: A Report From an International DLBCL Rituximab-CHOP Consortium Program Study

MYC/BCL2 Protein Co-Expression Defines a Unique Subset of Aggressive Lymphoma and Contributes to the Inferior Prognosis of Activated B-cell Subtype of Diffuse Large B-cell Lymphoma: A Report from the International DLBCL Rituximab-CHOP Consortium Program Study

Suchergebnisse filtern